发明名称 |
PHARMACEUTICAL COMPOSITION FOR TREATING HEMORRHAGE CAUSED BY BLOOD CLOTTING DISORDER AND USE THEREOF |
摘要 |
<p>The present invention belongs to the emergency treatment field of critically ill patients and involves a pharmaceutical composition used to treat coagulation disorder hemorrhage and its purpose and methods to treat the patients bleeding due to coagulation disorder. Containing L-ornithine 0.5ˆ¼8g, aspartic acid 1ˆ¼5g, arginine 3~10g and vitamin B6 3-10g per unit, the pharmaceutical composition is effective in treating the hemorrhagic patients caused by coagulation dysfunction, especially in treating critically ill patients.</p> |
申请公布号 |
EP2601951(A1) |
申请公布日期 |
2013.06.12 |
申请号 |
EP20100855546 |
申请日期 |
2010.12.10 |
申请人 |
YUE, MAOXING;WAN, HONGGUI;HUANG, TONGGE |
发明人 |
YUE, MAOXING;WAN, HONGGUI;HUANG, TONGGE |
分类号 |
A61K31/4415;A61K31/197;A61K31/198;A61K31/375;A61K31/401;A61K31/405;A61K31/4172;A61K31/4188;A61K31/455;A61K31/51;A61K31/519;A61K31/525;A61K31/714;A61P7/04 |
主分类号 |
A61K31/4415 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|